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25-175 mg/day) and 20 received maintenance prednisolone duce the cytokine interleukin-6 ( Il-6), also the main (mean 5.6±2.0 mg/day). 25/38 patients had one or more inflammatory and 'acute-phase response' (APR) mediepisodes of acute rejection, treated with a 3-day course of ator of fibrinogen transcription [10, 11] . The G/A−455 methylprednisolone 500 mg and/or antithymocyte globulin.
polymorphism in the b-fibrinogen promoter is associ-Diagnoses were glomerulonephritis (n=12), reflux nephroated with variation in fibrinogen levels in the general pathy (n=5), adult polycystic kidney disease (n=7), population. Smoking is associated with elevated fib-unknown cause (n=4), and miscellaneous diseases in the rinogen level but the difference between smokers and remaining 10 patients including two with diabetic nephronon-smokers is greater in carriers of the A−455 allele, pathy, both receiving insulin. Twenty-four patients were compared with homozygotes for the G−455 allele [12, receiving antihypertensive agents, 16 patients were receiving diuretics and/or beta blockers, and two patients were re-13 ]. This may be mediated by a differential response ceiving pravastatin. Two patients had nephrotic-range of the A allele to a smoking-related increase in pulmonproteinuria, one due to recurrent mesangiocapillary glomary macrophage-derived IL6.
erulonephritis and the other chronic transplant glomerulopaFactor VII coagulant activity ( VIIc) has also been thy. Thirty-one controls free of overt renal or cardiac disease identified in prospective studies as a CVD risk factor, were recruited from hospital staff and their spouses. Twelve most strongly associated with fatal cardiovascular of the controls and eight of the RTR were current smokers events [4, 14 ] . Factor VII is a vitamin-K-dependent defined as regular tobacco use within the last 5 years. None coagulation factor that is synthesized in the liver and of the controls but nine of the RTR (including one diabetic circulates as an inactive zymogen. Activation of coagu-patient) had CVD ( 3 cerebrovascular disease, 1 cerebral and lation follows exposure of activated factor VII ( VIIa) peripheral vascular disease, 1 abdominal aortic aneurysm repair, and 4 ischaemic heart disease).
to sub-endothelial or macrophage-derived tissue factor CVD risk in this population are unknown. In order to LDL-cholesterol was measured after precipitation of VLDL study the potential effect of the altered environmental using SDS and subtraction of the measured HDL. HDLmilieu of renal transplantation upon plasma fibrinogen cholesterol was measured after precipitation of other fracand VIIc, and the influence of variation at their tions by heparin and MnCl 2 . VLDL-cholesterol was calcurespective gene loci in contributing to CVD risk, we lated as the difference (Total−(LDL+HDL)). Fibrinogen measured fibrinogen, VIIc, the prothrombin activation was measured by the Clauss method and VIIc by a onestage bioassay utilizing bovine brain thromboplastin.
pepetide F1+2, the cross-linked fibrin degradation Commercially available ELISA kits were used to measure product D-Dimer ( DD), the acute-phase cytokine IL6 
Subjects

DNA methods
Thirty-eight stable ethnically homogeneous renal transplant recipients at least 1 year post-transplant (median 5, range Genomic DNA was prepared from whole blood by a standard method [ 25] . Specific oligonucleotide primers were used to 1-16) were recruited from the annual review clinic of the Oxford Transplant Centre. Thirty-five of the 38 were receiv-PCR-amplify appropriate regions of the b-fibrinogen [26 ] and factor VII [18 ] genes as described in detail previously. ing maintenance cyclosporin A (CsA) (mean 4.0±1.0 mg/kg day), 34/38 received azathioprine (median 100, range The fibrinogen PCR product was digested with the restriction enzyme HaeIII followed by electrophoresis through a 1% sex (fibrinogen, males 363±57 versus females agarose gel in 40 mM Tris-acetate 1 mM EDTA pH 7.7 345±54 mg/dl; VIIc, 91±29 versus 103±39 %std, containing 0.5 mg/ml ethidium bromide and visualization mean±SD) or prednisolone use (fibrinogen, Pred+ under UV light. HaeIII digestion gave a constant fragment (n=20) 349±60 versus Pred− 362±53 mg/dl, P>0. ence (FPLSD) was used to determine which pairs of groups There were no significant differences between genodiffered significantly when the ANOVA was significant. type or allele frequencies in control versus RTR groups Linear correlations were assessed by Pearson's correlation coefficient (r) or Spearman's rank correlation (r s ) as indicated. and the genotype distributions in all groups did not A forward stepwise multiple linear regression method which differ significantly from Hardy-Weinberg equilibrium. selects the next independent variable with the highest partial The frequency of the b-fibrinogen A−455 allele was correlation (F ) with the dependent variable, with recalcula-0.26 and 0.23 respectively and the frequency of the tion of the partial F for each remaining independent variable factor VII Gln 353 allele was 0.13 and 0.17. One RTR− after inclusion, was used. Statistics were performed using was homozygous for the b-fibrinogen A−455 allele and Statview SE (Abacus Concepts, USA) statistical analysis was included with the heterozygotes for statistical program and significance was defined as P<0.05.
analysis, but no Gln 353
homozygotes were found; 8/9 RTR with CVD complications and 11/12 with any Results additional disease complication ( RTR+) were homozygous for the factor VII Arg 353 allele. The increment in mean fibrinogen associated with In order to study the effect of renal transplantation independently of additional disease state complications the A−455 allele was 3, 22 and 36 mg/dl in controls, RTR− and RTR+ respectively ( Table 4a) . Assessing which influence coagulation, the 12 patients with either CVD ( 8), diabetes and CVD (1), diabetes (1 ) or the effect of smoking according to fibrinogen genotype was impeded by the small numbers of smokers in each nephrotic syndrome (2), were grouped together (designated RTR+) and were compared with the 26 RTR genotype; however, no significant difference was detected between smokers and non-smokers according free of these conditions (designated RTR−) and the 31 controls. Metabolic, demographic and environ-to fibrinogen genotype in either group (results not shown). The correlation between fibrinogen and CsA mental data for these three groups are shown in Table 1. varied (non-significantly) according to the b-fibrinogen genotype (GG−455 r=0.18 P>0.3 versus GA−455 r= The RTR− were similar in age, sex and BMI with controls but RTR+ were significantly older and were 0.50 P=0.11).
Mean VIIc was 30, 26 and 34% lower in Gln 353 more hyperlipidaemic than the controls. Creatinine, trough CsA levels, and median urinary protein concen-carriers compared with Arg 353 homozygotes in controls (P<0.01), RTR− (P<0.005) and RTR+ (P=0.2) tration were comparable for each RTR group. The three patients not receiving CsA are in the RTR+ respectively. VIIc was not significantly higher than controls in the RTR− group, but significantly group; however, their exclusion does not significantly modify the results, but division into genotype groups increased in the RTR+ group (Table 4b ) . When the positive correlations noted between VIIc with plasma further reduces the size of RTR groups, so they have been included in the analysis.
TG and CsA in the whole RTR population were analysed by the factor VII genotype and disease status, Haemostatic data are shown in Table 2 . Compared with the controls, RTR-had significantly higher fib-only the RTR+ Arg 353 homozygotes continued to show a positive correlation between VIIc and TG (r= rinogen, IL6, DD and F1+2, but not VIIc. The RTR+ group had a further increment in fibrinogen, 0.58, P=0.08), and between VIIc and CsA (r=0.65, P=0.06), although the number of heterozygotes was IL6, DD and F1+2, and a significantly raised VIIc. Fibrinogen was significantly higher in the RTR+ small.
In a stepwise regression model using fibrinogen as group compared with RTR− (P<0.05]. Neither fibrinogen nor VIIc varied significantly according to the dependent variable, and age, BMI, CsA level, cross-linked fibrin. There is evidence of activation of the extrinsic pathway of coagulation ( VIIc) and a higher fibrinogen level, consistent with the literature F1+2, b-fibrinogen genotype and CVD status as independent variables, only age (partial F=14.7) and CsA [21] [22] [23] , and the elevation in plasma fibrinogen appeared to be independent of early acute rejection level (F=4.6) remained as significant independent variables accounting for 41% of the variability in episodes. These prothrombotic changes are present in transplant patients without any additional disease comfibrinogen levels. In a stepwise regression with VIIc as plications, and exacerbated in those with cardiovas-mental or genetic factors, or perhaps because circulating IL6 does not necessarily represent the local cular or metabolic disease complications suggesting that renal transplantation per se is associated with a action of the cytokine. Comparison with a group of RTR not receiving CsA may be informative, as the hypercoagulable state independent of the changes superimposed by, or predisposing to, the presence of literature suggests these patients have a smaller increment in fibrinogen [21, 22 ] . an additional disease complication such as atherosclerosis.
Increased release of fibrin degradation products such as DD would maintain increased fibrinogen levels via Increased IL6 concentrations in the transplant population, who were a median of 5 years post-transplant, a positive feedback loop mediated through IL6 [33 ] , although no significant correlation between IL6 and is consistent with a low grade but persistent acutephase response (APR). IL6 is the principal cytokine DD was noted in this study. However the correlation between fibrinogen and F1+2 in this and other studies that mediates the APR and induces co-ordinate transcription of the three fibrinogen genes [27] . IL6 gene (34, 35) is consistent with a rise in fibrinogen induced by coagulation activation. expression is suppressed by steroids [28 ] , but in this study no difference in IL6 or fibrinogen was noted in
Other environmental factors could potentially contribute to fibrinogen elevation in RTR. Fibrinogen patients receiving maintenance prednisolone compared with those withdrawn from this agent, possibly due to levels are increased in patients with nephrotic syndrome [8] , and in essential hypertension with and without the low maintenance steroid dose. Cyclosporin A has been shown to increase IL6 gene expression and IL6 micro-albuminuria [36, 37] . In this study, no significant correlation with urinary protein concentration was production in monocytes in vitro [29] [30] [31] and the persistence of elevated circulating IL6 in long-term shown and exclusion of the three patients with heavy proteinuria or diabetes had no effect on the results transplant patients receiving CsA could be related to chronic exposure to this drug. Consistent with this (data not shown). However the majority of patients had low levels of protein loss and it is possible that in hypothesis, fibrinogen independently correlated with CsA blood levels in the whole population. This correla-a larger study, with greater variability of proteinuria, the influence of protein loss may become more evident. tion was stronger in carriers of the A−455 allele, who also had a trend to higher fibrinogen levels, than in A weak correlation with both systolic and diastolic blood pressure was found, consistent with studies in patients homozygous for the G−455 allele. This is consistent with findings of a more dramatic association untreated hypertensive populations but, as two-thirds of the patients were receiving antihypertensive agents, of the A−455 allele with raised plasma fibrinogen in smokers compared with non-smokers [12, 13] and of this correlation may be an underestimate. The role of persistence of subclinical viral and bacterial infection a strong association between fibrinogen and genotype in an acutely ill population [32 ] . This could be due to may also be relevant but was not explored in this study, although patients with overt infection were greater inducibility of the A−455 allele in response to IL6, and is currently under further study. However, a excluded.
Raised plasma fibrinogen is strongly associated with direct correlation between IL6 and CsA levels was not found in this study, perhaps because of greater variabil-the extent of coronary artery disease in patients with established CVD, and also highly predictive of future ity in IL6 production determined by either environ-CVD events in those initially free of overt disease. The References Northwick Park Heart Study demonstrated that a by monocyte/macrophages [41] .
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In summary, long-term CsA-treated RTR manifest 
